连续脏替代疗法和Cytosorb对Cefiderocol药理学的影响:"一个尺寸不适合所有人"
Gabriella Bottari1, Guzzo Isabella2, Cecchetti Corrado1
1Pediatric Intensive Care Unit, Ospedale Pediatrico Bambino Gesù (IRCSS), Rome, Italy.
The International journal of artificial organs
|March 18, 2025
概括
在连续脏替代疗法和血液吸收等体外疗法期间,Cefiderocol的去除有所不同. 治疗药物监测对于优化重症患者的塞菲德罗科尔剂量至关重要,以达到预期的疗效.
科学领域:
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
背景情况:
- 塞菲德罗科尔是一种新型的头素,有效对抗耐卡巴胺的格拉姆阴性细菌.
- 在体外治疗过程中,对塞菲德罗科尔的药理动力学 (PK) 和药理动力学 (PD) 尚不清楚.
- 危急病患者通常需要体外疗法,如连续脏替代疗法 (CRRT) 和血液吸收 (HA).
研究的目的:
- 在接受连续静脉静脉血液过 (CVVHDF) 和Cytosorb® HA的重症患者中评估 cefiderocol 的 PK/PD 概况.
- 评估这些体外疗法期间的 cefiderocol 清除和清除.
- 确定这些疗法的影响,以实现 cefiderocol PK/PD 目标.
主要方法:
- 一个16岁的男性病例报告,患有复发的B细胞白血病,多器官衰竭和败血性休克.
- 使用治疗药物监测 (TDM) 监测的Cefiderocol PK/PD.
- 在CVVHDF和HA会话期间对 cefiderocol 清除和清除的分析.
主要成果:
- 塞菲德罗科尔表现出对CVVHDF和HA的去除敏感性.
- 在最初的120-180分钟内通过HA观察到显著的塞菲德罗科尔去除.
- CVVHDF显示了受废水速率影响的波动性 cefiderocol 清除率.
- 在71.4%的病例中,达到了PK/PD疗效目标 (Cmin/MIC ≥4),观察到可变性.
结论:
- 身体外疗法显著影响着 cefiderocol PK/PD.
- 个性化抗生素剂量策略对于在体外支持下重症患者来说是必要的.
- 可能需要考虑剂量调整,例如在早期HA或延长输注期间.
- 在这种患者群体中,TDM对于优化Cefiderocol治疗至关重要.
相关概念视频
01:11Renal Failure: Dose Adjustments
51
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
51
01:09Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
79
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
79
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
152
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
152
01:17Hepatic Drug Excretion: Enterohepatic Cycling
887
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
887
01:17Factors Affecting Renal Clearance: Renal Impairment
45
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
45
01:15Drug Elimination by Renal Route: Tubular Secretion
2.1K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.1K